Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
33.04
-1.69 (-4.87%)
Mar 31, 2025, 10:11 AM EDT - Market open

Crinetics Pharmaceuticals Statistics

Total Valuation

CRNX has a market cap or net worth of $3.07 billion. The enterprise value is $1.93 billion.

Market Cap 3.07B
Enterprise Value 1.93B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

CRNX has 93.05 million shares outstanding. The number of shares has increased by 39.11% in one year.

Current Share Class 93.05M
Shares Outstanding 93.05M
Shares Change (YoY) +39.11%
Shares Change (QoQ) +14.24%
Owned by Insiders (%) 1.42%
Owned by Institutions (%) 110.16%
Float 91.72M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3,110.28
Forward PS 638.61
PB Ratio 2.44
P/TBV Ratio 2.44
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1,856.81
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 23.04, with a Debt / Equity ratio of 0.04.

Current Ratio 23.04
Quick Ratio 22.83
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -32.02% and return on invested capital (ROIC) is -21.53%.

Return on Equity (ROE) -32.02%
Return on Assets (ROA) -20.46%
Return on Invested Capital (ROIC) -21.53%
Return on Capital Employed (ROCE) -24.65%
Revenue Per Employee $2,378
Profits Per Employee -$682,856
Employee Count 437
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -21.83% in the last 52 weeks. The beta is 0.58, so CRNX's price volatility has been lower than the market average.

Beta (5Y) 0.58
52-Week Price Change -21.83%
50-Day Moving Average 36.05
200-Day Moving Average 48.37
Relative Strength Index (RSI) 46.96
Average Volume (20 Days) 956,794

Short Selling Information

The latest short interest is 7.77 million, so 8.35% of the outstanding shares have been sold short.

Short Interest 7.77M
Short Previous Month 8.11M
Short % of Shares Out 8.35%
Short % of Float 8.47%
Short Ratio (days to cover) 7.58

Income Statement

In the last 12 months, CRNX had revenue of $1.04 million and -$298.41 million in losses. Loss per share was -$3.69.

Revenue 1.04M
Gross Profit -239.12M
Operating Income -338.85M
Pretax Income -258.54M
Net Income -298.41M
EBITDA -336.07M
EBIT -338.85M
Loss Per Share -$3.69
Full Income Statement

Balance Sheet

The company has $1.35 billion in cash and $51.72 million in debt, giving a net cash position of $1.30 billion or $14.00 per share.

Cash & Cash Equivalents 1.35B
Total Debt 51.72M
Net Cash 1.30B
Net Cash Per Share $14.00
Equity (Book Value) 1.32B
Book Value Per Share 14.26
Working Capital 1.32B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$225.97 million and capital expenditures -$3.84 million, giving a free cash flow of -$229.81 million.

Operating Cash Flow -225.97M
Capital Expenditures -3.84M
Free Cash Flow -229.81M
FCF Per Share -$2.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -32,613.47%
Pretax Margin -28,720.69%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRNX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -39.11%
Shareholder Yield -39.11%
Earnings Yield -9.23%
FCF Yield -7.11%

Analyst Forecast

The average price target for CRNX is $73.36, which is 122.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target $73.36
Price Target Difference 122.03%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (5Y) 310.49%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CRNX has an Altman Z-Score of 20.75 and a Piotroski F-Score of 2.

Altman Z-Score 20.75
Piotroski F-Score 2